Canadian Randomized Trial of Hemoglobin Maintenance to Prevent or Delay Left Ventricular Mass Growth in Patients With CKD

This publication has 19 references indexed in Scilit:

• Development, Prevention, and Potential Reversal of Left Ventricular Hypertrophy in Chronic Kidney Disease
  Journal of the American Society of Nephrology, 2004
• Evaluation of the results of a randomized controlled trial: how to define changes between baseline and follow-up
  Journal of Clinical Epidemiology, 2004
• Effects of Early and Late Intervention with Epoetin α on Left Ventricular Mass among Patients with Chronic Kidney Disease (Stage 3 or 4)
  Journal of the American Society of Nephrology, 2004
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
  American Journal of Kidney Diseases, 1999
• Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
  American Journal of Kidney Diseases, 1996
• Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
  Kidney International, 1995
• Methods for assessing difference between groups in change when initial measurement is subject to intra‐individual variation
  Statistics in Medicine, 1993
• Impact of left ventricular hypertrophy on survival in end-stage renal disease
  Kidney International, 1989
• Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
  Published by Elsevier ,1986